147 related articles for article (PubMed ID: 16584506)
1. The influences of hyperprolactinemia and obesity on cardiovascular risk markers: effects of cabergoline therapy.
Serri O; Li L; Mamputu JC; Beauchamp MC; Maingrette F; Renier G
Clin Endocrinol (Oxf); 2006 Apr; 64(4):366-70. PubMed ID: 16584506
[TBL] [Abstract][Full Text] [Related]
2. Different effects of cabergoline and bromocriptine on metabolic and cardiovascular risk factors in patients with elevated prolactin levels.
Krysiak R; Okopien B
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):251-6. PubMed ID: 25123447
[TBL] [Abstract][Full Text] [Related]
3. Level of serum IL-12 and its correlation with endothelial dysfunction, insulin resistance, proinflammatory cytokines and lipid profile in newly diagnosed type 2 diabetes.
Mishra M; Kumar H; Bajpai S; Singh RK; Tripathi K
Diabetes Res Clin Pract; 2011 Nov; 94(2):255-61. PubMed ID: 21855158
[TBL] [Abstract][Full Text] [Related]
4. Author's reply: the influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy.
Serri O
Clin Endocrinol (Oxf); 2007 Jul; 67(1):159. PubMed ID: 17465996
[No Abstract] [Full Text] [Related]
5. Plasma adiponectin levels are related to obesity, inflammation, blood lipids and insulin in type 2 diabetic and non-diabetic Trinidadians.
Nayak BS; Ramsingh D; Gooding S; Legall G; Bissram S; Mohammed A; Raychaudhuri A; Sahadeo B; Pandohie V; Figaro K
Prim Care Diabetes; 2010 Oct; 4(3):187-92. PubMed ID: 20580627
[TBL] [Abstract][Full Text] [Related]
6. The influences of hyperprolactinaemia and obesity on cardiovascular risk markers: effects of cabergoline therapy.
Schmid C; Brändle M
Clin Endocrinol (Oxf); 2006 Dec; 65(6):827-8. PubMed ID: 17121538
[No Abstract] [Full Text] [Related]
7. High-sensitive C-reactive protein, tumor necrosis factor alpha, and cardiovascular risk factors before and after weight loss in obese children.
Reinehr T; Stoffel-Wagner B; Roth CL; Andler W
Metabolism; 2005 Sep; 54(9):1155-61. PubMed ID: 16125526
[TBL] [Abstract][Full Text] [Related]
8. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
Alghasham AA; Barakat YA
Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
[TBL] [Abstract][Full Text] [Related]
9. Decreased high-density lipoprotein cholesterol is associated with inflammation and insulin resistance in non-diabetic haemodialysis patients.
Peng YS; Chiu YL; Chen HY; Yang JY; Lai CF; Hsu SP; Pai MF
Nephrology (Carlton); 2010 Oct; 15(7):692-9. PubMed ID: 21040164
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S
Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747
[TBL] [Abstract][Full Text] [Related]
11. Relation of chemokines to BMI and insulin resistance at ages 18-21.
Ognjanovic S; Jacobs DR; Steinberger J; Moran A; Sinaiko AR
Int J Obes (Lond); 2013 Mar; 37(3):420-3. PubMed ID: 22508338
[TBL] [Abstract][Full Text] [Related]
12. Impact of weight loss on inflammatory proteins and their association with the insulin resistance syndrome in morbidly obese patients.
Kopp HP; Kopp CW; Festa A; Krzyzanowska K; Kriwanek S; Minar E; Roka R; Schernthaner G
Arterioscler Thromb Vasc Biol; 2003 Jun; 23(6):1042-7. PubMed ID: 12714437
[TBL] [Abstract][Full Text] [Related]
13. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects.
Beilfuss J; Berg V; Sneve M; Jorde R; Kamycheva E
Cytokine; 2012 Dec; 60(3):870-4. PubMed ID: 22925537
[TBL] [Abstract][Full Text] [Related]
14. The levels of circulating markers of atherosclerosis and inflammation in subjects with different degrees of body mass index: Soluble CD40 ligand and high-sensitivity C-reactive protein.
Guldiken S; Demir M; Arikan E; Turgut B; Azcan S; Gerenli M; Tugrul A
Thromb Res; 2007; 119(1):79-84. PubMed ID: 16476470
[TBL] [Abstract][Full Text] [Related]
15. Oral glucose tolerance test effects on endothelial inflammation markers in healthy subjects and diabetic patients.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Fogari E; Gravina A; Mereu R; Palumbo I; Maffioli P; Randazzo S; Cicero AF
Horm Metab Res; 2010 Jan; 42(1):8-13. PubMed ID: 19735057
[TBL] [Abstract][Full Text] [Related]
16. Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity.
Kar P; Laight D; Rooprai HK; Shaw KM; Cummings M
Diabet Med; 2009 May; 26(5):526-31. PubMed ID: 19646193
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular risk profile of patients with psoriatic arthritis compared to controls--the role of inflammation.
Tam LS; Tomlinson B; Chu TT; Li M; Leung YY; Kwok LW; Li TK; Yu T; Zhu YE; Wong KC; Kun EW; Li EK
Rheumatology (Oxford); 2008 May; 47(5):718-23. PubMed ID: 18400833
[TBL] [Abstract][Full Text] [Related]
18. A comparison of osteoprotegerin with adiponectin and high-sensitivity C-reactive protein (hsCRP) as a marker for insulin resistance.
O'Sullivan EP; Ashley DT; Davenport C; Penugonda L; Kelleher G; Devlin N; Crowley R; O'Shea P; Agha A; Thompson CJ; O'Gorman DJ; Smith D
Metabolism; 2013 Jan; 62(1):34-8. PubMed ID: 22841521
[TBL] [Abstract][Full Text] [Related]
19. Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome.
Benson S; Janssen OE; Hahn S; Tan S; Dietz T; Mann K; Pleger K; Schedlowski M; Arck PC; Elsenbruch S
Brain Behav Immun; 2008 Feb; 22(2):177-84. PubMed ID: 17716857
[TBL] [Abstract][Full Text] [Related]
20. The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency.
Deepak D; Daousi C; Javadpour M; Clark D; Perry Y; Pinkney J; Macfarlane IA
Growth Horm IGF Res; 2010 Jun; 20(3):220-5. PubMed ID: 20185347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
